Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
J Dermatol Sci ; 54(2): 99-105, 2009 May.
Article in English | MEDLINE | ID: mdl-19264456

ABSTRACT

BACKGROUND: Psoriasis is a chronic immune-mediated skin disease, in which interleukins 12 and 23 have been postulated to play a critical role. However, the cellular source of these cytokines in psoriatic lesions are still poorly defined and their relative contribution in inducing skin inflammation has been discussed controversially. OBJECTIVES: To investigate immunoreactivity of the bioactive forms of IL-12 and IL-23 in plaque psoriasis and to characterize the dendritic cell (DC) and macrophage subsets responsible for the production of these cytokines. METHODS: Immunohistochemistry was performed on normal skin (n=11) as well as non-lesional (n=11) and lesional (n=11) skin of patients with plaque psoriasis using monoclonal antibodies targeting the bioactive forms of IL-12 (IL-12p70) and IL-23 (IL-23p19/p40) on serial cryostat sections using the alkaline phosphatase-antialkaline phosphatase. Co-localization of IL-12 and IL-23 with different dendritic cells and macrophage cell markers (CD1a, CD11c, CD14, CD32, CD68, CD163, CD208/DC-LAMP) was performed using double immunofluorescence staining. RESULTS: Immunoreactivity for IL-12 and IL-23 was significantly enhanced in lesional psoriatic skin as compared to non-lesional and normal skin. No difference was observed between IL-12 and IL-23 immunoreactivity in any skin types. Both IL-12 and IL-23 immunoreactivity was readily detected mainly in CD11c+, CD14+, CD32+, CD68+ and some CD163+, DC-LAMP+ cells. IL-12 and occasionally IL-23 were also found in some CD1a+ dendritic cells. In addition, an enhanced expression mainly of IL-23 was observed in keratinocytes. CONCLUSIONS: Bioactive forms of IL-12 and IL-23 are highly expressed in various DC and macrophage subsets and their marked in situ production suggest that both cytokines have crucial pathogenic role in psoriasis.


Subject(s)
Dendritic Cells/immunology , Interleukin-12/biosynthesis , Interleukin-23 Subunit p19/biosynthesis , Macrophages/immunology , Psoriasis/immunology , Skin/immunology , Adult , Aged , Aged, 80 and over , Dendritic Cells/cytology , Female , Humans , Keratinocytes/immunology , Macrophages/cytology , Male , Middle Aged , Psoriasis/pathology , Skin/pathology
2.
J Dtsch Dermatol Ges ; 4(2): 141-2, 2006 Feb.
Article in German | MEDLINE | ID: mdl-16503942

ABSTRACT

Treatment of pyogenic granuloma may be difficult in locations such as the face and fingertips. We successfully treated a 1 cm periungual fingertip pyogenic granuloma with a dye laser.


Subject(s)
Fingers , Granuloma, Pyogenic/radiotherapy , Low-Level Light Therapy , Nail Diseases/radiotherapy , Adult , Follow-Up Studies , Humans , Male
3.
Eur J Dermatol ; 16(1): 79-83, 2006.
Article in English | MEDLINE | ID: mdl-16436349

ABSTRACT

Mycobacterium marinum can cause fish tank granuloma (or swimming pool or aquarium granuloma) in immunocompetent patients. Dissemination of Mycobacterium marinum-infection is a rare condition which occurs mainly in immunocompromised patients and can be life-threatening. We report the case of an 87-year-old woman who was treated with oral corticosteroids for polymyalgia rheumatica for many years and developed erythema nodosum-like lesions on the right forearm and arthritis of the right wrist. By increasing the steroid dosage and adding methotrexate only short-term remission was achieved. Seven months later painful erythematous nodules occurred on all extremities which became necrotic, ulcerative and suppurative. Ziehl-Neelsen staining revealed acid-fast bacilli and Mycobacterium marinum was cultured from skin biopsies, blood, and urine. The critically ill patient was treated with clarithromycin and ethambutol resulting in a dramatic improvement of the general condition. After four months, doxycycline had to be added because of new skin lesions. This case illustrates the impact of Mycobacterium marinum infection in immunocompromised patients.


Subject(s)
Bacteremia/drug therapy , Bacteremia/microbiology , Mycobacterium Infections, Nontuberculous/diagnosis , Mycobacterium Infections, Nontuberculous/drug therapy , Mycobacterium marinum/isolation & purification , Aged , Aged, 80 and over , Anti-Bacterial Agents/therapeutic use , Antitubercular Agents/therapeutic use , Bacteremia/physiopathology , Critical Illness , Drug Therapy, Combination , Female , Follow-Up Studies , Humans , Immunocompromised Host , Immunosuppressive Agents/adverse effects , Immunosuppressive Agents/therapeutic use , Mycobacterium Infections, Nontuberculous/immunology , Polymyalgia Rheumatica/diagnosis , Polymyalgia Rheumatica/drug therapy , Polymyalgia Rheumatica/immunology , Risk Assessment , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...